5National Kidney Foundation. NKF-K/DOQI clinical prac tice guidelines and clinical practice recommendations.-2006 updates[J]. Am J Kidney Dis, 2006,48 Suppl 1 :S1-S32. 被引量：1
6Ethier J, Mendelssohn DC, Eider SJ, et al. Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study[J]. Neplarol Dial Transplant,2008,23(10) :3219-3226. 被引量：1
7Cetinkaya R, Odabas AR,Unlu Y, et al. Using cuffed and tunneled central venous catheters as permanent vascular access for hemodialysis:a prospective study[J] .Ren Fail, 2003,25(3) :431-438. 被引量：1
8Moran JE, Ash SR. ASDIN Clinical Practice Committee Locking solutions for hemodialysis catheters;heparin and citrate-a position paper by ASDIN[J].Semin Dial,2008, 21 (5) :490-492. 被引量：1
9Sonawane S, Kasbekar N, Berns JS. The safety of heparins in end-stage renal disease[J]. Semin Dial, 2006, 19 (4) : 305-310. 被引量：1
10Sombolos KI, Fragia TK, Bamichas GI, et al. Heparin solution locked in acute hemodialysis catheters: impact on activated partial thromboplastin time[J]. ASAIO J, 2003, 49(3) :287-289. 被引量：1
